semaglutide cardiovascular risk The weight-loss drug Wegovy lowered heart attack in a large trial GLP-1 receptor agonists can reduce
Description
Many of the initial, exciting studies were conducted on animal models
But theory isnt enough
This underpins the strategy intended to position Pfizer as a leader in the next generation of obesity therapies
It does not alter insulin sensitivity
